We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Autologous Transplant of EFS-ADA Modified Bone Marrow Cells for ADA-Deficient Severe Combined Immunodeficiency (SCID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01852071
Recruitment Status : Active, not recruiting
First Posted : May 13, 2013
Last Update Posted : September 27, 2017
National Institute of Allergy and Infectious Diseases (NIAID)
National Human Genome Research Institute (NHGRI)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Donald B. Kohn, M.D., University of California, Los Angeles

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : July 2018
  Estimated Study Completion Date : September 2018